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A B S T R A C T
Background: One of the mechanisms of Staphylococcus aureus resistance to ciprofloxacin is the presence of efflux
pumps. The aim of this study was to determine the frequency and expression of norA, norB and norC efflux pump
genes in ciprofloxacin-resistant Staphylococcus aureus clinical isolates.
Materials and methods: In this study, 40 isolates of S. aureus were obtained from blood and urine samples.
Antibiotic resistance pattern by disc diffusion method and the minimum inhibitory concentration (MIC) was
evaluated. Identification and expression of nor efflux family genes (norA, norB, and norC) in ciprofloxacin-
resistant isolates of S. aureus were determined using Real-Time PCR method.
Results: The resistant to ciprofloxacin, Gentamicin, Cotrimoxazol, Erythromycin and Amoxicillin was 42.5%,
12.5%, 12.5%, 50% and 87.5%, respectively. All of ciprofloxacin-resistant isolates were positive for of norA,
norB, and norC genes. The results of Real-Time PCR showed that all ciprofloxacin-resistant isolates are active in
the case of efflux pumps. Isolates showed different expressions of the norA, norB and norC genes. Expression
levels of norA and norB increased by 6.8 and 7.1 fold, respectively.
Conclusion: The results indicated that nor efflux family genes were expressed in all ciprofloxacin-resistant iso-
lates of S. aureus. Moreover, there is an association between the expression of the efflux pump genes and re-
sistance to ciprofloxacin in S. aureus isolates.
1. Introduction
Staphylococcus aureus is a bacterial pathogen from the
Micrococcaceae family, which is a common bacterial pathogen in hos-
pital-acquired infections around the world. The anterior portion of the
nose is the primary source of S. aureus in adults and children, and be-
tween 20% to 40% of healthy individuals are the carriers of this bac-
terium (Corredor Arias et al., 2016).This bacterium causes a wide range
of diseases including pneumonia, skin infections, endocarditis, and os-
teomyelitis (Hefzy et al., 2016; Osman et al., 2016). Methicillin-re-
sistant Staphylococcus aureus (MRSA) is one of the opportunistic pa-
thogens in the hospital whose resistance to methicillin is mediated by
producing a specific penicillin-binding protein called PBP2a encoded by
the mecA gene (Petrović-Jeremić et al., 2016; Udobi et al., 2013).
Today, MRSA strains are resistant to most conventional β-lactam
antibiotics, such as oxacillin, which limits the treatment of MRSA-
mediated diseases (Gómez et al., 2016; Ersoy et al., 2019). Fluor-
oquinolone drugs such as ciprofloxacin are one of the most appropriate
and alternative drugs for the treatment of MRSA strains (Firsov et al.,
2008).
However, following administration of this antibiotic for the treat-
ment of infections, bacterial resistance to antibiotics has occurred. In
some cases, the resistance level was 100% (Mustapha et al., 2016).
Antibiotic resistance mechanisms are different in S. aureus strains.
One of the mechanisms is to prevent drug accumulation inside the cell
through efflux pump systems which transport toxic substances such as
antibiotics into the environment (Poole, 2007; Li and Nikaido, 2009;
Kosmidis et al., 2012; Paulsen and Lewis, 2002).
Antimicrobial efflux systems have been classified into five families
based on their energy source and structure namely, the small multidrug
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resistance (SMR) family; the major facilitator superfamily (MFS); the
resistance-nodulation-cell division (RND) superfamily; the multidrug
and toxic compound extrusion (MATE) family; and the adenosine-tri-
phosphate (ATP)-binding cassette (ABC) superfamily (Li and Nikaido,
2009; Soto, 2013; Costa et al., 2013). Efflux pumps are effectively re-
levant to the major facilitator superfamily (MFS) and the resistance-
nodulation-cell division (RND) superfamily that contribute to the re-
moval of antibiotics using the proton motive force (Li and Nikaido,
2009).
The MFS transport system is one of the main efflux systems in S.
aureus and NorA pump is one of the major pumps in this family. The
efflux pump NorA is encoded by the chromosomal gene norA and
contains 388 amino acids. Several studies have shown that norA can
transport various compounds such as hydrophilic fluoroquinolones in-
cluding norfloxacin, ciprofloxacin, ethidium bromide, and quaternary
ammonium compounds outside the cell (Yoshida et al., 1990; Noguchi
et al., 2004). Researchers have shown that the norA gene has a basal
expression in cells causing a low resistance to antibiotic compounds.
Increased resistance to fluoroquinolones is associated with an over-
expression of norA efflux pump (Hooper and Jacoby, 2015).
The norB pump is another MFS proton-driven efflux pump in S.
aureus, which is encoded by the chromosomal gene norB and contains
463 amino acids. It is responsible for the resistance to fluoroquinolones
and biocides. Previous studies have shown that this pump is also im-
portant in increasing the pathogenicity of this bacterium (Truong-
Bolduc et al., 2005).
The norC pump belongs to the MFS family and is encoded by
chromosomal gene norC and contains462 amino acids. NorC con-
tributes to low-level resistance to hydrophilic and hydrophobic fluor-
oquinolones such as garenoxacin, moxifloxacin, and ciprofloxacin (Li
and Nikaido, 2009; Hooper and Jacoby, 2015).
In the clinical approaches, the first choice for the treatment of MRSA
infections is the ciprofloxacin antibiotic. Today, the biggest challenge
and concern in hospitals is a hospital-acquired infection (HAI) with
opportunistic S. aureus, which has been resistant to both methicillin and
ciprofloxacin antibiotics.
The purpose of the present study was to evaluate the expression
levels of efflux pump genes including norA, norB, and norC in cipro-
floxacin-resistant isolates.
2. Material and methods
2.1. Bacterial strain identification
In this descriptive study, a total of 40 S. aureus isolates were re-
covered from blood and urine samples from Imam Khomeini Hospital,
Tehran, Iran during the second 6months of the year 2018. Isolates were
identified using Gram staining, catalase test, Mannitol fermentation and
DNase and detection of the grlA gene by PCR.
2.2. Antimicrobial susceptibility testing
After identifying S. aureus isolates, the antibiotic susceptibility of
bacteria was investigated by a disc diffusion method against cipro-
floxacin (5 μg), Gentamicin (10 μg), Cotrimoxazol (25 μg),
Erythromycin (15 μg), and Amoxicillin (30 μg) (UK, MAST) in Hinton
Muller agar medium (Merck, Germany). The results were interpreted
according to CLSI (Clinical and Laboratory Standards Standard 2015,
Institute) guidelines.
The susceptibility of strains to ciprofloxacin was rechecked by broth
micro dilution method in triplicates in accordance with CLSI guideline.
2.3. Primer design
The sequences of primers in this study were designed by Oligo 7 and
Primer 3 software (Table 1) (Rychlik, 2007).
2.4. PCR amplification
DNA extraction was done using Genomic DNA Extraction Kit
(Bioneer, Republic of Korea). The presence of norA, B, and C genes in
isolates were tested by PCR, using the primers described in Table 1. The
PCR reaction mixture with the final volume of 20 μl was prepared and
DNA amplification was performed in a thermal cycler with denatura-
tion at 94 °C for 4min, followed by 35 cycles of denaturation at 94 °C
for 30 s, annealing at 60 °C for 30 s, and an extension at 72 °C for 20 s
plus a final extension at 72 °C for 4min.
2.5. Analysis of norA, norB and norC gene expression levels by Real-Time
PCR
The sub-MIC concentration of ciprofloxacin was used for RNA ex-
traction. The bacteria in the sub-MIC were collected and pelleted
through centrifugation at 2500×g for 15min. RNAs were extracted via
the RNeasy Plus Mini Kit (Qiagen, USA) according to the manufacturer's
instructions.
Subsequently, cDNA synthesis was performed using Easy cDNA re-
verse transcription (Parstous, Iran). Evaluation of norA, norB, and norC
expression levels was performed by quantitative time-real PCR (qPCR),
in Rotor-Gene thermal cycler (Corbett 6000; Australia). A final volume
of 20 μl PCR reaction mix containing 2 μl of cDNA, 10 μl SYBR Green
master mix, 6 μl nuclease-free water and 1 μl of each primer (Table 1)
was run according to the following program: initial activation step at
94 °C for 4min, 35 cycles of denaturation at 94 °C for 30 s, annealing at
60 °C for 30 s and extension at 72 °C for 20 s. The 16srRNA gene was
used as an internal control to normalize target genes expression mea-
surements. Real-Time PCR results were analyzed using the 2(−Delta
Delta C(T)) method (Livak and Schmittgen, 2001).
2.6. Data analysis
Data were analyzed with Mann Whitney U test using GraphPad
Prism 6 program. The P-value for statistical significance is defined as
P < 0.05.
3. Results
In the present study, a total of 40 S. aureus isolates were confirmed
by different biochemical tests and PCR using specific primer for grlA
gene. Twenty-nine (72.5%) of S. aureus isolates were obtained from 29
blood samples and 11 isolates were obtained from urine sample.
The susceptibility test results of S. aureus in the study showed 42.5%
resistance to ciprofloxacin, 12.5% resistance to Gentamicin, 12.5% re-
sistance to Cotrimoxazol, 50% resistance to Erythromycin, and 87.5%
resistance to Amoxicillin.
In the next step, the minimum inhibitory concentration of cipro-
floxacin was performed by microdilution broth for 40 isolates.
According to MIC results, 17 isolates (42.5%) were resistant to cipro-
floxacin. The MIC results showed that out of 17 fluoroquinolones re-
sistant isolates using disc diffusion method, 6 isolates (35%-6/17) had
the minimum inhibitory concentration in the resistant range
(MIC≥ 1mg/ml), 3 isolates (17%-3/17) with the minimum inhibitory
concentration in the semi-sensitive range (MIC= 0.12–0.5mg/ml) and
8 isolates (47%-8/17) had the minimum inhibitory concentration in the
sensitive area (MIC≤0.06mg/ml) (Table 2).
3.1. PCR and Real-Time PCR
In order to investigate the presence of efflux pump genes in isolates
from S. aureus, specific primers for these genes were designed. The
expected PCR bands size for norA, norB, and norC genes were 121 bp,
160 bp, and 132 bp, respectively which were observed in all 15 resistant
isolates. In Real-Time PCR assay, all isolates in sub-MIC concentration
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showed a different expression of efflux pump genes. There was a sta-
tistically significant difference between the expression of norA and norB
genes in comparison with expression of 16srRNA gene as internal
control (p≤ 0.05).
In isolates with sub-MIC concentration, the expression of norA and
norB genes were similarly increased by 6.8 and 7.1 fold, while the ex-
pression of norC gene was low and 2.8 fold increased in comparison to
the control (Fig. 1). Real-Time PCR data showed that in resistant iso-
lates, norA and norB pumps may play a more important role than norC
in resistance to ciprofloxacin.
4. Discussion
The mechanism of resistance to quinolones is different in bacteria.
In E. coli bacterium, the mechanism of resistance to quinolones is due to
the alteration of the DNA structure of the gyrase (Nakanishi et al.,
1998). As mentioned earlier, one of the mechanisms of resistance to
ciprofloxacin in strains of S. aureus is the presence of efflux pumps
(Hassanzadeh et al., 2017). These pumps transport a wide range of
materials including antibiotics, antiseptic compounds, dyes, and de-
tergents. Therefore, they play a significant role in the development of
multi-drug resistance. In general, this efflux pump genes are located on
chromosome and are conserved among the strains.
In recent years, resistance to quinolones has been reported in MRSA
strains (Moreno-Flores et al., 2018). In the United States, ciprofloxacin-
resistant MRSA strains developed three months after using cipro-
floxacin (Motallebi et al., 2016).
As noted, MRSA strains are one of the most important pathogens in
hospitals that spread rapidly worldwide. This organism is resistant to
most beta-lactam antibiotics and there are few substitutes for this drug
(Ghosh and Banerjee, 2016). One of the alternative therapies is the
ciprofloxacin therapy from the quinolone family; however, recent stu-
dies have shown increased resistance to this antibiotic. In this study,
among 40 clinical isolates, 17 isolates were ciprofloxacin-resistant
(42.5%) by micro dilution method. The difference between the result of
disc diffusion and broth micro dilution methods shows that MIC de-
tection methods can be more accurate and more sensitive than disc
diffusion methods.
Different studies have been conducted on the phenotypic and gen-
otypic identification of efflux pumps in S. aureus strains. Present study
was performed to evaluate the frequency of norA, norB, and norC efflux
pump genes and their expression in ciprofloxacin-resistant isolates of S.
aureus.
In our study, norA, norB and norC genes were present in all cipro-
floxacin resistant isolates in MIC method. Similar results are reported in
other studies. Hoove et al. (Huet et al., 2008) tested 9 ciprofloxacin
resistant MRSA strains for the presence of efflux pumps and expression
in the presence of low concentrations of antibiotics using Real-Time
PCR method. The results of this study showed that norA and norB genes
were present in all resistant strains and their expression increased along
with the increase in antibiotic concentrations.
Pourmand et al. (2014) also checked the presence of norA pump
gene and its expression in ciprofloxacin-resistant strains by Real-Time
PCR method. The results of this study showed that norA gene exists in
all ciprofloxacin-resistant isolates and its expression is increased in the
presence of the biocide hexahydroquinolone.
Our results are in agreement with previous studies, resistance to
ciprofloxacin have been increased among the clinical isolates of S.
aureus. norA, B, and C were present in all resistant isolates and their
expression increased in comparison to the control.
The results of this study showed that norA and norB is one of the
most important mechanisms in resistance to fluoroquinolone antibiotics
such as ciprofloxacin, but the role of other factors and mechanisms
involved in resistance should not be ignored. Finally, further studies are
essential for production and the expansion of new anti-oxidant-in-
hibiting molecules. The development of efflux pumps inhibitors makes
it possible to control resistant strains.
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Table 1
Primer used in qPCR.
Genes Primer sequence (5′→ 3′) Amplicon (bp) Tm (°C) References
norA F AATGCCTGGTGTGACAGGTT 121 60 This study
R TCCACCAATCCCTGGTCCTA
norB F AAAAGCCGTCAAGAGAGGCA 160 60 This study
R ACGGCGATATTAACCGTTCCA
norC F GTTCTTGGGGTGGAAGTGGT 132 60 This study
R CAGGCGTCCCTTTGATGAGT
16srRNA F ATGGTTGTTGCAAACCTGCC 117 60 This study
R GCGTTCGCCCACTTCTTTTT
Table 2
Minimum inhibitory concentration of ciprofloxacin among isolates.
Break point Ciprofloxacin
Resistance (≥1) Intermediate (0.12–0.5) Sensitive (≤0.06)
MIC (μg/ml) ≥1 0.12–0.5 ≤0.06
Isolates 6 3 8
Total 17
Fig. 1. Relative expression of norA, B and C efflux pump genes in clinical iso-
lates of S.aureus. In ciprofloxacin-resistant isolates, the expression of norA, norB
and norC genes increase>6.8, 7.1 and 2.8 fold, respectively. Asterisk indicates
significant difference between two groups by Mann Whitney U test (P < 0.05).
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